Delivery Order SPE2DB22D3501-SPE2DB25FVM08
Award Date
4/29/25
Potential Completion Date
5/20/25
Potential Value
$26K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $106,187.70 firm fixed-price contract is for the supply of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a specialty pharmaceutical product. The contract has an ultimate completion date of February 18, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $26,285.93 firm fixed-price contract is for the supply of ULTOMIRIS 300 MG/3 ML VIAL 3ML, a prescription medication. The contract has an ultimate completion date of May 1, 2025 and is not set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $48,668.88, is for the supply of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a specialty medication, to support military healthcare programs. The contract is a Firm Fixed Price (FFP) arrangement and has an ultimate completion date of February 12, 2025. It is not designated as a set-aside contract....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $51,070.20, is for the supply of ULTOMIRIS 300 MG/3 ML VIAL 3ML, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 20, 2024. The contract was not designated with any set-aside requirements, indicating open...
This is a $17,523.90 firm fixed price delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the procurement of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML. The contract has an ultimate completion date of April 14, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of ULTOMIRIS 1,100 mg/11 ml vials, with a potential value of $93,652.38 and a completion date of March 25, 2024. Amerisourcebergen Drug Corp is the prime contractor and serves as a major supplier of pharmaceuticals and medical supplies to the Department...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a pharmaceutical product. The contract has a firm fixed price, with a potential value of $125,000.72, and a completion date of January 25, 2024. The place of performance is Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. This delivery order is not...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a specialty pharmaceutical product, with a potential value of $93,652.38 and a completion date of March 28, 2024. The contract does not have a set-aside...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,779.26, is for the delivery of ULTOMIRIS 300 MG/3 ML VIAL 3ML. It is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 21, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a for-profit organization...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML medical products. The contract, valued at $192,762.90, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract is a delivery order type with a firm fixed price pricing structure, and has an ultimate completion date of March 25, 2025....